-
Mashup Score: 5Testosterone Supplements: Overcoming Current Misconceptions - 3 month(s) ago
About one fifth of patients with symptomatic testosterone deficiency receive treatment, partly because of misconceptions about the risks for therapy.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Pharma Fridays – January 12, 2024 - Endocrine News - 3 month(s) ago
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Pilot Study Announced Exploring the Effect of Oral Testosterone Therapy (CIII testosterone undecanoate capsules) on Male Fertility On January 9, Marius Pharmaceuticals, announced it has initiated a pilot study to better understand the effect of oral testosterone replacement therapy, KYZATREX® (testosterone undecanoate), on spermatogenesis…
Source: endocrinenews.endocrine.orgCategories: General Medicine News, EndocrinologyTweet-
Pharma Fridays - Jan. 12, 2024 @MariusPharma announced pilot study to better understand the effect of oral #testosterone replacement therapy, KYZATREX® (testosterone undecanoate), on spermatogenesis in adult males. https://t.co/z67598qF0W
-
-
Mashup Score: 7Researchers find testosterone hormone therapy for transmasculine individuals is safer than previously thought - 5 month(s) ago
A common concern about gender-affirming hormone therapy for transmasculine people is the risk of red blood cell volume changes and erythrocytosis, a high concentration of red blood cells, with the use …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet-
Researchers find #testosterone hormone therapy for transmasculine individuals is safer than previously thought @mountsinainyc https://t.co/S8a956KFGV
-
-
Mashup Score: 19
Scientific Reports – Lower serum testosterone is associated with increased likelihood of arthritis
Source: www.nature.comCategories: General Medicine News, General NewsTweet-
Lower #testosterone correlated to higher rates of osteoarthritis in a non-dose–dependent way @SciReports https://t.co/SD1vECUBMw https://t.co/diKGFrZRtm
-
-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Results from a new preclinical study show #ProstateCancer cells sense decreased levels of #testosterone caused by anti-hormone therapy and respond by signaling an increase in #cholesterol needed to produce testosterone that fuels tumor growth. https://t.co/SmgmlMzFh9 https://t.co/1KpyeKBIMw
-
-
Mashup Score: 2
For decades, there has been controversy about whether testosterone therapy has deleterious effects on the risk of major cardiovascular events in older men. As the number of prescriptions for testosterone therapy has escalated, this controversy has heightened.1 Although some epidemiological studies have suggested an association between testosterone therapy and risk of major cardiovascular events, an equal (or greater) number of epidemiological studies have demonstrated no increase or even a decreased risk associated with testosterone therapy.
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet-
In the Current Issue: Bradley D Anawalt comments on: The #TRAVERSE trial: #cardiovascular safety of #testosterone therapy for older men https://t.co/Asgu6IGajt #hypogonadism
-
-
Mashup Score: 2
For decades, there has been controversy about whether testosterone therapy has deleterious effects on the risk of major cardiovascular events in older men. As the number of prescriptions for testosterone therapy has escalated, this controversy has heightened.1 Although some epidemiological studies have suggested an association between testosterone therapy and risk of major cardiovascular events, an equal (or greater) number of epidemiological studies have demonstrated no increase or even a decreased risk associated with testosterone therapy.
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet-
In the October Issue: The #TRAVERSE trial: #cardiovascular safety of #testosterone therapy for older men https://t.co/Asgu6IGI91 #hypogonadism
-
-
Mashup Score: 2The Lancet Diabetes & Endocrinology, August 2023, Volume 11, Issue 8, Pages 525-624, e10 - 7 month(s) ago
Explore the current issue of The Lancet Diabetes & Endocrinology, a monthly journal focussed on diabetes, endocrinology, and metabolism
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet-
The October Issue of @TheLancetEndo is now online, featuring life expectancy in type 2 #diabetes, #adrenocortical carcinoma, #thyroid function and #cardiovascular disease, #T1D, early-onset #T2D, #craniopharyngioma, #testosterone, #CGM & #bariatric surgery https://t.co/lyBpHtUCUl https://t.co/38LTYSZf31
-
-
Mashup Score: 1
For decades, there has been controversy about whether testosterone therapy has deleterious effects on the risk of major cardiovascular events in older men. As the number of prescriptions for testosterone therapy has escalated, this controversy has heightened.1 Although some epidemiological studies have suggested an association between testosterone therapy and risk of major cardiovascular events, an equal (or greater) number of epidemiological studies have demonstrated no increase or even a decreased risk associated with testosterone therapy.
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet-
Online—The TRAVERSE trial: #cardiovascular safety of #testosterone therapy for older men https://t.co/Asgu6IGI91 #hypogonadism
-
-
Mashup Score: 2
For decades, there has been controversy about whether testosterone therapy has deleterious effects on the risk of major cardiovascular events in older men. As the number of prescriptions for testosterone therapy has escalated, this controversy has heightened.1 Although some epidemiological studies have suggested an association between testosterone therapy and risk of major cardiovascular events, an equal (or greater) number of epidemiological studies have demonstrated no increase or even a decreased risk associated with testosterone therapy.
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet-
"For older men with bona fide hypogonadism, testosterone therapy is unlikely to significantly increase major adverse cardiovascular events during the first few years" https://t.co/Asgu6IGajt #testosterone #cardiovascular #hypogonadism
-
#Testosterone supplements: Overcoming current misconceptions https://t.co/zG4rY1GTob https://t.co/lwdWLTXJIW